Clinical Trial Detail

NCT ID NCT03922555
Title ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

malignant glioma

Therapies

ASTX727

Age Groups: adult senior

Additional content available in CKB BOOST